Tu Youyou is a Chinese pharmaceutical chemist and malariologist whose groundbreaking work on traditional Chinese medicine led to the discovery of artemisinin, a compound that has saved millions of lives from malaria. Born on December 30, 1930, in Ningbo, Zhejiang Province, China, she grew up during a turbulent period in Chinese history that included the Japanese occupation and the early years of the People's Republic. Her early education was interrupted by illness; as a teenager she contracted tuberculosis and spent several years recovering, an experience that deepened her interest in medicine and healing.
After recovering, Tu enrolled at Peking University Medical School (then known as Beijing Medical College) in 1951, studying in the Department of Pharmacy. She graduated in 1955 and was assigned to the Academy of Traditional Chinese Medicine in Beijing, where she would spend the majority of her career. In the late 1950s and early 1960s she received specialized training that combined modern pharmaceutical methods with classical Chinese materia medica. This dual foundation—scientific rigor paired with deep knowledge of traditional herbal texts—proved decisive in her later research.
In 1967, during the Cultural Revolution, China launched a secret military research program known as Project 523. Its goal was to find new treatments for malaria, a disease that was killing large numbers of Chinese soldiers and civilians in Southeast Asia and Africa, and for which existing drugs such as chloroquine were rapidly losing effectiveness because of resistance. Tu Youyou was appointed head of a research group at the Academy of Traditional Chinese Medicine tasked with screening traditional remedies. Working under difficult conditions—limited laboratory equipment, political pressure, and personal hardship—she and her team systematically examined more than two thousand traditional Chinese recipes and tested hundreds of herbal extracts.
The breakthrough came from an ancient text, the Handbook of Prescriptions for Emergencies written by Ge Hong in the fourth century. The text described a preparation of the plant qinghao (sweet wormwood, Artemisia annua) that was said to reduce intermittent fevers. Earlier modern attempts to extract an active compound from the plant had failed because the extraction methods used heat, which destroyed the active ingredient. Tu carefully reread the classical description, which recommended soaking the fresh plant in cold water, and realized that a low-temperature extraction was essential. In 1971 her team succeeded in isolating an extract that was highly effective against malaria parasites in animal models. Further refinement produced a pure crystalline compound that was named artemisinin (or qinghaosu in Chinese).
Clinical trials began in 1972. Tu herself volunteered as one of the first human subjects to confirm the safety of the extract. The results were dramatic: patients with severe malaria, including those infected with chloroquine-resistant strains, recovered rapidly. Artemisinin and its derivatives—artesunate, artemether, and others—proved faster-acting and less toxic than previous antimalarials. Because the parasite could develop resistance to single compounds, the World Health Organization later recommended artemisinin-based combination therapies (ACTs) as the first-line treatment for uncomplicated Plasmodium falciparum malaria. These combinations remain the global standard today.
The scientific community outside China remained largely unaware of the discovery for many years because of the secrecy surrounding Project 523 and the limited publication of results in Chinese-language journals. International recognition came slowly. In the 1980s and 1990s, researchers in other countries confirmed the structure and efficacy of artemisinin and developed improved derivatives. By the early twenty-first century, ACTs were estimated to have reduced malaria mortality dramatically in many endemic regions. According to World Health Organization figures, the scale-up of artemisinin-based treatments, together with insecticide-treated bed nets and other interventions, contributed to a substantial decline in global malaria deaths between 2000 and 2015.
Tu Youyou’s contributions were formally recognized with the Lasker-DeBakey Clinical Medical Research Award in 2011 and, most notably, the Nobel Prize in Physiology or Medicine in 2015. She shared the prize with William C. Campbell and Satoshi Ōmura, who had discovered avermectin, another antiparasitic agent. At the age of eighty-four, Tu became the first Chinese woman to receive a Nobel Prize in science and the first Chinese scientist to be awarded the Nobel Prize in Physiology or Medicine for work conducted entirely within China. In her Nobel lecture she emphasized the value of integrating traditional knowledge with modern scientific methods, stating that Chinese medicine is a “great treasure-house” that still holds untapped potential.
Despite the honors, Tu remained characteristically modest. She continued to work at what is now the China Academy of Chinese Medical Sciences well into her later years, focusing on the mechanisms of artemisinin and the search for additional antimalarial compounds. She has consistently credited her colleagues and the classical Chinese medical literature rather than claiming sole credit. Her personal life was marked by the same quiet determination that characterized her science; she married Li Tingzhao, an engineer, and they raised two daughters while she pursued demanding research under often austere conditions.
The impact of artemisinin extends far beyond the laboratory. Malaria still kills hundreds of thousands of people each year, predominantly children under five in sub-Saharan Africa, yet the availability of effective treatment has transformed the disease from a near-certain death sentence in many areas into a manageable illness when diagnosed promptly. Resistance to artemisinin has begun to appear in parts of Southeast Asia, underscoring the need for continued research and the development of new drugs—an effort in which Tu’s example of patient, methodical investigation remains relevant.
Tu Youyou’s career also illustrates larger themes in the history of science: the importance of open-minded engagement with traditional knowledge, the value of persistence under political and material constraints, and the long lag that sometimes separates discovery from global recognition. Her work bridges ancient herbal practice and contemporary pharmaceutical chemistry, demonstrating that careful reading of historical sources, combined with rigorous experimental testing, can yield results of profound human benefit. In an era when drug resistance and emerging infectious diseases continue to challenge medicine, her achievement stands as a reminder that solutions may still be found in unexpected places—provided researchers are willing to look carefully and think differently.
Today Tu Youyou is regarded in China as a national scientific hero and internationally as one of the most consequential pharmacologists of the twentieth century. Her discovery has been estimated to have saved more than two hundred million lives. The story of artemisinin continues to inspire researchers exploring natural products for new medicines, while the plant Artemisia annua itself has become the subject of agricultural and synthetic biology efforts aimed at ensuring a stable global supply of the drug. Through quiet dedication rather than self-promotion, Tu Youyou transformed an ancient remedy into a modern lifesaving therapy and left an enduring legacy in the fight against one of humanity’s oldest and most persistent scourges.